1 min read News Reviews U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients Alisan Duran May 29, 2022 Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are...Read More